Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$115.19 - $132.77 $63,354 - $73,023
-550 Reduced 9.67%
5,138 $618,000
Q4 2023

Feb 12, 2024

BUY
$114.26 - $136.0 $131,170 - $156,128
1,148 Added 25.29%
5,688 $699,000
Q3 2023

Oct 27, 2023

SELL
$122.0 - $145.31 $23,180 - $27,608
-190 Reduced 4.02%
4,540 $587,000
Q2 2023

Aug 09, 2023

SELL
$122.5 - $147.16 $48,020 - $57,686
-392 Reduced 7.65%
4,730 $586,000
Q1 2023

May 10, 2023

BUY
$133.98 - $160.47 $26,126 - $31,291
195 Added 3.96%
5,122 $749,000
Q4 2022

Feb 06, 2023

SELL
$129.72 - $159.85 $2,853 - $3,516
-22 Reduced 0.44%
4,927 $784,000
Q3 2022

Nov 07, 2022

BUY
$126.59 - $161.18 $15,443 - $19,663
122 Added 2.53%
4,949 $655,000
Q2 2022

Aug 04, 2022

SELL
$141.59 - $168.66 $67,396 - $80,282
-476 Reduced 8.98%
4,827 $753,000
Q1 2022

May 10, 2022

BUY
$129.64 - $160.7 $25,798 - $31,979
199 Added 3.9%
5,303 $826,000
Q4 2021

Feb 10, 2022

SELL
$119.87 - $145.67 $48,067 - $58,413
-401 Reduced 7.28%
5,104 $650,000
Q3 2021

Nov 09, 2021

SELL
$128.64 - $184.79 $33,446 - $48,045
-260 Reduced 4.51%
5,505 $717,000
Q2 2021

Aug 11, 2021

BUY
$160.2 - $186.42 $213,546 - $248,497
1,333 Added 30.08%
5,765 $977,000
Q1 2021

May 14, 2021

SELL
$150.19 - $173.5 $61,577 - $71,135
-410 Reduced 8.47%
4,432 $728,000
Q4 2020

Feb 16, 2021

SELL
$140.71 - $165.05 $19 Million - $22.3 Million
-135,118 Reduced 96.54%
4,842 $799,000
Q3 2020

Nov 10, 2020

BUY
$105.46 - $144.13 $1.09 Million - $1.49 Million
10,359 Added 7.99%
139,960 $20 Million
Q2 2020

Aug 13, 2020

BUY
$95.68 - $121.88 $2.02 Million - $2.58 Million
21,134 Added 19.48%
129,601 $14.3 Million
Q1 2020

May 15, 2020

BUY
$87.74 - $152.74 $4.43 Million - $7.71 Million
50,475 Added 87.04%
108,467 $10.8 Million
Q4 2019

Feb 11, 2020

BUY
$117.65 - $153.73 $4.28 Million - $5.6 Million
36,399 Added 168.57%
57,992 $8.66 Million
Q3 2019

Nov 07, 2019

BUY
$125.18 - $143.24 $16,273 - $18,621
130 Added 0.61%
21,593 $2.77 Million
Q2 2019

Aug 01, 2019

SELL
$125.55 - $144.48 $1.3 Million - $1.49 Million
-10,324 Reduced 32.48%
21,463 $3.06 Million
Q1 2019

May 08, 2019

SELL
$121.81 - $142.95 $1.31 Million - $1.53 Million
-10,715 Reduced 25.21%
31,787 $4.54 Million
Q4 2018

Feb 01, 2019

BUY
$115.94 - $166.74 $183,880 - $264,449
1,586 Added 3.88%
42,502 $5.27 Million
Q3 2018

Nov 01, 2018

SELL
$161.01 - $180.57 $1.72 Million - $1.93 Million
-10,696 Reduced 20.72%
40,916 $6.88 Million
Q2 2018

Jul 31, 2018

BUY
$146.33 - $183.18 $632,291 - $791,520
4,321 Added 9.14%
51,612 $8.89 Million
Q1 2018

May 11, 2018

BUY
$135.59 - $157.16 $4.21 Million - $4.88 Million
31,048 Added 191.15%
47,291 $7.14 Million
Q4 2017

Feb 02, 2018

BUY
$131.06 - $150.39 $39,055 - $44,816
298 Added 1.87%
16,243 $2.19 Million
Q3 2017

Nov 09, 2017

BUY
$142.62 - $155.6 $2.27 Million - $2.48 Million
15,945
15,945 $2.33 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.